A Cochrane review included 54 studies (50 in the meta-analyses), containing 5660 patients, of whom 586 had proven or probable invasive aspergillosis. When using an optical density index (ODI) of 0.5 as a cut-off value, the sensitivity of the test was 82% (73% to 90%) and the specificity was 81% (72% to 90%). At a cut-off value of 1.0 ODI, the sensitivity was 72% (65% to 80%) and the specificity was 88% (84% to 92%). At a cut-off value of 1.5 ODI, the sensitivity was 61% (47% to 75%) and the specificity was 93% (89% to 97%). None of the potential sources of heterogeneity had a statistically significant effect on either sensitivity or specificity.
At the cut-off value 0.5 ODI in a population of 100 patients with an overall median disease prevalence of 8%, 2 patients who have IA will be missed and 17 patients will be treated or further referred unnecessarily. At the cut-off value 1.5 the figures would be 3 and 5, respectively. The role of the galactomannan detection test in clinical decision making remains unclear.Comment: The quality of evidence is downgraded by inconsistency (variability in results across studies).